Provided by Tiger Trade Technology Pte. Ltd.

Harte-Hanks

2.37
+0.00500.21%
Post-market: 2.370.00000.00%16:10 EDT
Volume:448.00
Turnover:1.03K
Market Cap:17.57M
PE:-21.55
High:2.37
Open:2.23
Low:2.23
Close:2.37
52wk High:5.39
52wk Low:2.23
Shares:7.41M
Float Shares:2.45M
Volume Ratio:0.06
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1100
EPS(LYR):-0.1100
ROE:-3.84%
ROA:0.62%
PB:0.86
PE(LYR):-21.55

Loading ...

Novo Nordisk: From Market Darling to Selloff Target — Should You Buy the Dip?

TradingKey
·
Dec 04, 2025

Ironwood Pharma’s LINZESS® Price Set by HHS

TIPRANKS
·
Nov 26, 2025

Rafa Laboratories Awarded up to $186 Million by BARDA to Develop a Life-Saving Intramuscular TXA Injection for Prehospital Care

prnewswire
·
Nov 19, 2025

Harte Hanks Reports Q3 Revenue of $39.5 Million and Net Loss of $2.3 Million

Reuters
·
Nov 11, 2025

Harte Hanks Q3 Pretax Profit USD 319 Thousand

THOMSON REUTERS
·
Nov 11, 2025

HHS removing ‘misleading’ FDA warnings on hormone replacement therapy

TIPRANKS
·
Nov 11, 2025

Top Premarket Decliners

MT Newswires Live
·
Oct 31, 2025

VSee Health Surges On Federal Approval, Opening Doors To More Government Partnerships

Benzinga
·
Oct 29, 2025

VSee Health awarded U.S. Department of HHS FedRAMP High ATO

TIPRANKS
·
Oct 28, 2025

Harte Hanks Announces Customer Care Center in Greenville with Samsung, Creating 150 Jobs

Reuters
·
Oct 22, 2025

CDC Reverses Hundreds Of Layoff Notices After Firing 1,300 Employees Amid Government Shutdown

Benzinga_recent_news
·
Oct 12, 2025

Coding Error Results in Mistaken Layoffs of CDC Staff Members

Deep News
·
Oct 12, 2025

Cidara Gets $339M from HHS for Non-Vaccine Influenza Preventative

Dow Jones
·
Oct 03, 2025

Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic

GlobeNewswire
·
Oct 03, 2025

Trump Administration Employs New Pressure Tactics as Harvard University Faces Potential Loss of Federal Funding Eligibility

Deep News
·
Sep 30, 2025